Effects of methylation and imprinting expression of Insulin-like growth factor 2 gene in gastric cancer
Cancer Biomarkers · 20.11.2023 · 38 (3) · 355-366
DOI: 10.3233/cbm-230105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, erschienen am 20.11.2023. Verfasst von Jiting Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Insulin-Like Growth Factor II. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Epstein-Barr virus (EBV)-associated gastric cancer (EBVaGC) is a common malignant tumor associated with EBV infection. Insulin-like growth factor 2 (IGF2) is an imprinted gene and a key protein that regulates growth, especially during normal fetal development. Loss of imprinting (LOI), is a common epigenetic anomaly in a variety of human cancers. However, the promoter methylation, imprinting status and function of IGF2 gene in GC are unclear. OBJECTIVE: To explore the role of IGF2 in the occurrence and development of gastric cancer. METHODS: The biological function of IGF2 in gastric cancer was investigated by Transwell, wound healing, CCK-8 and flow cytometry assays. IGF2 imprinting status and gene promoter methylation in gastric cancer tissues were detected by PCR-RFLP and BGS. RESULTS: The results showed that the expression of IGF2 was higher in GC tissues than adjacent tissues. IGF2 gene promoter methylation and LOI were significantly higher in EBVaGC tissues than in EBV-negative gastric cancer (EBVnGC) tissues. The high expression of IGF2 in gastric cancer can promote the migration and proliferation of gastric cancer cells. CONCLUSION: Our data suggest that IGF2 is involved in the occurrence and development of gastric cancer. Targeting IGF2 may be a potential therapeutic target for gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China.
- Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, and Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
- Department of Clinical Laboratory, Zibo Central Hospital, Zibo, Shandong, China.
Zitieren
APA
Sun, J., Shu, J., Shi, D., Liu, W., Zhang, Y., & Luo, B. (2023). Effects of methylation and imprinting expression of Insulin-like growth factor 2 gene in gastric cancer. Cancer Biomarkers, 38(3), 355-366. https://doi.org/10.3233/cbm-230105
Vancouver
Sun J, Shu J, Shi D, Liu W, Zhang Y, Luo B. Effects of methylation and imprinting expression of Insulin-like growth factor 2 gene in gastric cancer. Cancer Biomarkers. 2023;38(3):355-366. doi:10.3233/cbm-230105
BibTeX
@article{Sun2023,
author = {Sun, Jiting and Shu, Jun and Shi, Duo and Liu, Wen and Zhang, Yan and Luo, Bing},
title = {Effects of methylation and imprinting expression of Insulin-like growth factor 2 gene in gastric cancer},
journal = {Cancer Biomarkers},
year = {2023},
volume = {38},
number = {3},
pages = {355--366},
doi = {10.3233/cbm-230105}
}
EUVIMED